TickerFactsScreenerDevelopers

Sigyn Therapeutics, Inc. (SIGY) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$400.0K2018: -$286.1K2019: -$143.7K2020: -$829.8K2021: -$1.77M2022: -$1.83M2023: -$1.38M2024: -$872.4K-$872.4K
2017Operating Cash Flow (USD)2024
Fiscal YearOperating Cash FlowChange YoY
2024-$872.4K+36.9%
2023-$1.38M+24.4%
2022-$1.83M-3.2%
2021-$1.77M-113.8%
2020-$829.8K-477.5%
2019-$143.7K+49.8%
2018-$286.1K+28.5%
2017-$400.0K—